Kylie A Hughes, NP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St, Pob 407, Oak Lawn, IL 60453 Phone: 708-684-7032 |
Anthony Huang, AGACNP Nurse Practitioner - Acute Care Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-5354 Fax: 708-684-1028 |
Caitlin Degenhardt, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-8000 |
Patricia Capers, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4750 W 101st St Apt 1a, Oak Lawn, IL 60453 Phone: 773-456-3517 |
Barbara Jean Thompson, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-4200 Fax: 708-520-1885 |
Alexandra Nicole Lyewski, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 5660 W 95th St Ste 4, Oak Lawn, IL 60453 Phone: 708-425-0112 Fax: 708-425-2785 |
Jessica Bara, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 4740 W 95th St, Oak Lawn, IL 60453 Phone: 800-323-8622 |
Meaghan Reich Carnevale, CRNP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 4400 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-2019 |
Katelyn Rose Bednarczyk Giese, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St Ste 205, Oak Lawn, IL 60453 Phone: 708-684-5430 Fax: 708-684-3355 |
Dalia Sawicki, Nurse Practitioner - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 4440 West 95th Street, Ashu, Oak Lawn, IL 60453 Phone: 708-684-8000 Fax: 708-684-1987 |
Katarzyna G Wilk, APRN Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 5851 W 95th St, Oak Lawn, IL 60453 Phone: 708-636-1601 |
Alexandria Lauren Barrett, Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-5580 |
Ms. Anna J Mikos, CNM Nurse Practitioner - Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4700 W 95th St Ste 303, Oak Lawn, IL 60453 Phone: 708-857-7230 Fax: 708-425-5779 |
Lisa Kukla, APN-BC Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 4400 W 95th St, Pob 407, Oak Lawn, IL 60453 Phone: 708-684-7026 Fax: 708-684-7040 |
Mr. Marcus Larrieu, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10837 S Cicero Ave, Oak Lawn, IL 60453 Phone: 773-636-7575 |
Ms. Laura Valeria Burokas, CPNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-1012 Fax: 708-684-4763 |
Kristin Jensen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-684-5580 |
Mrs. Sofia Mitchell, CPNP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 4440 W 95th St, Oak Lawn, IL 60453 Phone: 708-780-9777 |
Mrs. Sarah Elizabeth Gonzales Zoeteman, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 4201 W 95th St, Oak Lawn, IL 60453 Phone: 708-636-8546 |
Natalia Katarzyna Buron, Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 9401 Ridgeland Ave, Oak Lawn, IL 60453 Phone: 708-599-6700 |
News Archive
A SARS-CoV-2 tracker uses publicly available sequencing data to show how the virus is changing and spreading over time. The tracker, called CovMT, was developed at KAUST and is expected to help researchers and policymakers understand the evolution of the virus's mutations.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
BELLUS Health announced today that it will discontinue its NC-503 diabetes development program following the results of the recently completed Phase IIa clinical proof-of-concept study evaluating NC-503 (eprodisate disodium) as a treatment for Type 2 diabetes. The study did not meet its primary efficacy endpoint.
A dramatic increase in the incidence of chronic inflammatory diseases such as asthma, allergy, and irritable bowel syndrome, has led to concern about how modern lifestyles may trigger physiological defense mechanisms.
› Verified 7 days ago